pd 169316 has been researched along with sphingosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamura, H; Kozawa, O; Matsuno, H; Uematsu, T | 1 |
| Harada, A; Ishisaki, A; Kanno, Y; Kozawa, O; Takenaka, M; Tokuda, H | 1 |
2 other study(ies) available for pd 169316 and sphingosine
| Article | Year |
|---|---|
p38 MAP kinase is involved in the signalling of sphingosine in osteoblasts: sphingosine inhibits prostaglandin F(2alpha)-induced phosphoinositide hydrolysis.
Topics: Animals; Blotting, Western; Dinoprost; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Hydrolysis; Imidazoles; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Osteoblasts; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositols; Phosphorylation; Pyridines; Signal Transduction; Sodium Fluoride; Sphingosine; Time Factors | 2000 |
Interleukin (IL)-17 enhances tumor necrosis factor-alpha-stimulated IL-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts.
Topics: Animals; Anisomycin; Cell Line; Dose-Response Relationship, Drug; Imidazoles; Interleukin-17; Interleukin-6; Lysophospholipids; Mice; Osteoblasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Sphingosine; Tumor Necrosis Factor-alpha | 2004 |